Immunopathology of Chagas disease - A historical overview

Chagas disease; immunophatology

Immunopathology of Chagas Disease - A Historical Overview

Suppl. I: 247-248

WL Tafuri

Departamento de Patologia Geral, ICB, Universidade Federal de Minas Gerais, Caixa Postal 486, 31270-901 Belo Horizonte, MG, Brasil

Key words: Chagas disease - immunophatology

There are several factors which directly or indirectly contribute to lesions produced by infection with Trypanosoma cruzi. Some of these factors are inherent to the parasite (initial parasite-host interactions which are ligand-specific, pleomorphism, tropism, virulence, genetic and antigenic constitution, parasite number of the inoculum, reinfection, parasite strains, clonal selection, mixed populations, etc.); others are related to the host (genetic constitution, sex, age, race, nutrition, immune response, professional macrophages and non-permissible cells, muscle cells, peripheral and central neuroglia, fibroblasts, mast cells and others). As in other infectious diseases, in Chagas disease, the mechanisms by which T. cruzi induces lesion are multi-faceted. Depending on these mechanism anatomo-clinical forms will or will not appear. By whatever means T. cruzi infects its host, any cell of different tissues and organs can be randomly infected. Several molecules (80 to 200 kDa) responsible for cell adhesion and penetration have been identified on the surface of the parasite (Bosghetti et al. 1987, Alves 1996). After gaining access into the cell, the parasite multiplies and, at this initial phase of the infection, are very aggressive since there is no immunity and no inflammatory reaction around parasitized cells. The escape from the parasitophorus vacuole into the host-cell is due to the action of a hemolysin which functions in acid pH. Thus, the host-cell bursts and both epi and tripomastigote parasite forms as well as organelles are released in the interstitium and work as an antigenic mosaic which will induce a rapid, parasite-specific and cell-mediated immune reaction. In consequence, an acute and focal inflammatory reaction with the exudation of mononucleated cells appears around areas of necrosis. This is seen most notably as myocarditis, myositis (both smooth and striated muscles), periganglionitis, ganglionitis, perineuritis and neuritis. With the progression of the immune response, parasite levels in blood and tissues drop. Nevertheless, the parasite is not completely eliminated, even in the presence of a Th1 lymphocyte response (IL-2 and IFN gamma) or circulating IgM and IgG antibodies.

The mechanisms underlying the ability of the parasite to escape the immune response are very complex and not completely understood. Several ideas have been pursued to explain such phenomenon, including the complexity and diversity of receptors needed for internalization, the escape from complement-mediated lysis, the endocytosis of antibodies by the parasite, the genetic polymorphism, the expression of several antigenic immunodeterminants at the same time, the antigenic mimetism, the suppression of the release of IFN gamma by Th1 lymphocytes, the polyclonal activation of T and B cells and the excessive production of TNF a. Although T. cruzi can infect any cell type, there are strains with a greater tropism for certain cells, tissues and organs. Thus, the different anatomo-clinical presentations of the disease will be determined by: (1) the tropism for different organs; (2) the intensity of parasitism; (3) the intensity of the inflammatory response; (4) the build-up and evolution of the immune response. Depending on these factors, anatomo-clinical forms, such as the cardiac or digestive forms, will develop into chronic fibrosing myocarditis with heart failure and/or in the megas, although tissue parasitism is almost absent. However a focal and/or diffuse inflammation is intense. Here, fibrosis (focal and diffuse fibrilopoesis) is the new observation not noticed in the acute forms. In our view, tissue fibrosis associated with parasympatic denervation is the major cause for the progressive functional loss of the affected organ (Tafuri 1979).

Although there is a vast literature about the subject, there is little known about the intimate immunological mechanisms which control the changes in local and general reactivity of the organisms during the evolution of the chagasic infection. For this reason, the reasons underlying the natural history of Chagas disease is still not known. The focal acute inflammation evolves to an asymptomatic chronic phase and the parasitism is suppose controlled by multiple mechanisms which include, complement fixation, antibodies and citotoxic lymphocytes (CD8+) which are activated by Th1-like CD4+ lymphocytes (Gazzinelli et al. 1998). In fact, the importance of cell-mediated immunity is exemplified by the observation that the parasitism becomes intense if any immunosuppression occurs (e.g. Aids, cyclophosphamide, and radiotherapy). Even though the cell-mediated immune response is effective, what are the underlying factors responsible for the modulation of the immune response in such way that 10-20 years after the initial infection the patient (20-30% of patients) evolves to significant organ malfunction, characterized by the megas and chronic fibrosing myocarditis? Even in these new anatomical forms of the disease, there is a low degree of parasitism, in contrast to an intense inflammation reaction. It remains the possibility that autoimmune mechanisms play a role in disease progression. Indeed, the role of autoimmunity in the genesis of the chronic chagasic myocarditis is supported by several authors including Santos-Buch and Acosta (1985), Kierzenbaum (1986), Santos et al. (1992), but contested by others Tarleton et al. (1997). Considering these ideas it appears that parasites and autoantigens are involved in the Chagas disease (Higushi et al. 1993, Reis et al. 1993, Cunha-Neto et al. 1995).

As one reads the vast literature on Chagas disease, it is easy to note an almost complete absence of studies about the structured and non-structured components of the extracelular matrix and their relation to the immune response in the acute and chronic phases of human and experimental Chagas. The extracelular matrix components of the heart are made of an intricate tridimensional net involving each cardiac muscle cell. These components are in constant and dynamic changes, which depend on a range of physiologic, homeostatic and immunological stimulus, such as those after aggression by pathogens (e.g. T. cruzi), and those of any fibrosing disease. As the extracelular matrix is in intimate contact with the cardiomyocytes, it is easy to understand that any quantitative or qualitative change in matrix expression may induce functional alterations of cardiomyocytes and the heart. Fibroblasts are the main cell type, which synthesize and release the different types of collagens where the alpha-ß1 integrin (metalopro-tease) plays an important role in the functions of the cell matrix (Kanekar 1998). Integrins are one of the four families of specific transmembrane receptors that are attached to the citoeskeleton. They are responsible for the transmission of signals from the matrix to the cells. It is our working hypothesis on Chagas disease that the immune response deviations are directly involved in the alterations of extracelular matrix. Macrophages, lymphocytes, fibroblasts and cytokines may play a central role in this context.

REFERENCES

Fax:[phone].

E-mail: [e-mail]

Received 9 June 1999

Accepted 9 August 1999

• Bestetti RB, Rossi MA 1997. A rational approach for mortality risk stratification in Chagas heart disease. Intern J Cardiol 58: 199-209.
• Cunha-Neto E, Duranti M, Gruber A, Zingales B, De Messias I, Stolf N, Bellotti G, Patarroyo ME, Pilleggi F, Kalil J 1995. Autoimmunity in Chagas disease cardiopathy: Biological relevance of a cardiac myosin specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 92: 3541-3545.
• Higushi M de L, Gutierrez PS, Aiello VD, Palomino S, Bocchi E, Kalil J, Belloti G, Pileggi F 1993. Immunohistochemical characterization of infiltrating cell in human chronic chagasic myocarditis: comparision with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 423: 157-160.
• Innis MA, Gelfand DH, Sninsky JJ, White TJ 1990. PCR Protocols, A Guide to Methods and Applications, Chapter 18, p.146-152. Academic Press, New York.
• Minoprio P, Eisen H, Fomi L, D'Imperio Lima MR, Joskowicz M, Coutinho A 1986. Polyclonal lymphocyte response to murine T. cruzi infection I. Quantitation of both T and B-cell responses. Scand J Immunol 24: 661-668.
• Moser DR, Kirchhoff LV, Donelson JE 1989. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol 27: 1477-1482.
• Requena JM, Jimenez-Ruiz A, Soto RM, Lopez MC, Alonso C 1992. Characterization of a highly repeated interspersed DNA sequence of Trypanosoma cruzi: its potential use in diagnosis and strain classification. Mol Biochem Parasitol 51: 271-280.
• Ribeiro-dos-Santos R, Rossi MA, Laus JL, Silva JS, Savino W, Mengel J 1992. Anti CD-4 abrogates rejection and reestablishes long-term tolerance to syngenic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175: 29-39.
• Rizzo LV, Cunha-Neto E, Teixeira ARL 1989. Autoimmunity in Chagas disease: specific inhibition of reactivity of CD4+T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 57: 2640-2644.
• Sambrook J, Fritsh EF, Maniatis T 1989. Molecular Cloning. A Laboratory Manual, Cold Spring Harbor, New York.
• Sturm NR, Degrave W, Morel C, Simpson L 1989. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas disease. Mol Biochem Parasitol 33: 205-214.
• Teixeira ARL 1987. Doença de Chagas e Outras Doenças por Tripanossomos, Universidade de Brasília, Brasília, 161 pp.
• Teixeira ARL, Argańaraz ER, Freitas Jr LM, Lacava ZGM, Santana JM, Luna H 1994. Possible integration of Trypanosoma cruzi kDNA minicircles into the host cell genome by infections. Mut Res 305: 197-209.
• Teixeira ARL, Cordoba JC, Souto-Maior Solorzano E 1990. Chagas disease: lymphoma growth in rabbits treated with benznidozole. Am J Trop Med Hyg 43: 146-158.
• Teixeira ARL, Lacava ZL, Santana JM, Luna H 1991. Inserçăo de DNA de Trypanosoma cruzi no genoma da célula hospedeira de mamíferos por meio de infecçăo. Rev Soc Bras Med Trop 24: 55-58.
• Van Voorkis WC, Schlekewy L, Trong HL 1991. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci USA 88: 5993-5997.

Publication Dates

• Publication in this collection
  18 Aug 2004
• Date of issue
  Sept 1999

History

• Accepted
  09 Aug 1999
• Received
  09 June 1999